Skip to main content
. 2022 Jun 1;9:886438. doi: 10.3389/fsurg.2022.886438

Table 3.

Details of the nonprophylactic-EVD group.

Value Preoperative hydrocephalus Postoperative hydrocephalus New Postoperative hydrocephalus
Benign 565(84%) 90(16%) 35(6%) 23(4%)
Malignant 110(16%) 46(42%) 12(11%) 1(1%)
Schwannoma 286(42%) 42(15%) 17(6%) 12(4%)
Meningoma 132(20.0%) 25(18.9%) 7(5.3%) 2(2%)
Hemangioblastoma 93(14%) 14(15%) 9(9%) 7(7%)
Glioma 59(9%) 18(31%) 9(15%) 1(2%)
Metastasis 29(4%) 9(31%) 1(3%) 0
Ependymoma 17(3%) 12(71%) 0 0
Cholesteatoma 17(3%) 1(6%) 0 0
Solitary fibrous tumor 12(2%) 1(8%) 0 0
Epidermoid cyst 9(1%) 1(11%) 0 0
Medulloblastoma 8(1%) 7(88%) 2(13%) 0
Choroid plexus papilloma 7(1%) 3(43%) 2(29%) 2(29%)
Arachnoid cyst 2(1%) 1(50%) 0 0
 Lymphoma 2(1%) 1(50%) 0 0
Teratoma 2(1%) 1(50%) 0 0
Total 675 136(20.1%) 47(7.0%) 24(3.6%)

EVD, external ventricular drainage.